AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2853441 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% nedocromil sodium nasal spray
Number of subjects: 38
Study 2853441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 30714388 — intervention group
Group type: COMPARATOR
Intervention: Visualization condition
Number of subjects: 47
Study 30714388 — intervention group
Group type: COMPARATOR
Intervention: Combined Calendaring and Alarm condition
Number of subjects: 47
Study 30714388 — intervention group
Group type: COMPARATOR
Intervention: Single session in-person intervention followed by tailored text messaging
Number of subjects: 47
Study 30714388 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 47
Study 27571889 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive web‐based sleep intervention based on cognitive behavioral therapy principles
Number of subjects: 30
Study 27571889 — intervention group
Group type: COMPARATOR
Intervention: Web‐based education program
Number of subjects: 30
Study 27419838 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable sutures (AS)
Number of subjects: 60
Study 27419838 — intervention group
Group type: COMPARATOR
Intervention: Non-adjustable sutures (NAS)
Number of subjects: 60
Study 23312069 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape seed extract powder (N31)
Number of subjects: 10
Study 23312069 — intervention group
Group type: EXPERIMENTAL
Intervention: Green coffee caffeine powder (N677)
Number of subjects: 10
Study 23312069 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole coffee fruit concentrate powder (WCFC)
Number of subjects: 10
Study 23312069 — intervention group
Group type: COMPARATOR
Intervention: Silica dioxide (placebo)
Number of subjects: 10
Study 23312069 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 10
Study 21098819 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-bundle (DB) reconstruction
Number of subjects: 53
Study 21098819 — intervention group
Group type: COMPARATOR
Intervention: Single-bundle (SB) reconstruction
Number of subjects: 53
Study 21098819 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (DB and SB)
Number of subjects: 53
Study 18727151 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine-induced hyperemia
Number of subjects: 0
Study 18727151 — intervention group
Group type: COMPARATOR
Intervention: Resting conditions
Number of subjects: 0
Study 18727151 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperemic conditions
Number of subjects: 0
Study 17306313 — intervention group
Group type: EXPERIMENTAL
Intervention: d-fenfluramine (DFEN) 45mg
Number of subjects: 18
Study 17306313 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 14761905 — intervention group
Group type: COMPARATOR
Intervention: General medicine trials
Number of subjects: 191
Study 14761905 — intervention group
Group type: COMPARATOR
Intervention: Psychiatric trials
Number of subjects: 191
Study 14761905 — intervention group
Group type: COMPARATOR
Intervention: Overall trials
Number of subjects: 191
Study 11123730 — intervention group
Group type: EXPERIMENTAL
Intervention: Right main stem bronchial intubation (Group A)
Number of subjects: 40
Study 11123730 — intervention group
Group type: COMPARATOR
Intervention: Low tidal volume-high frequency ventilation (Group B)
Number of subjects: 40
Study 9023165 — intervention group
Group type: EXPERIMENTAL
Intervention: Oversizing at normal balloon pressures (group 1)
Number of subjects: 20
Study 9023165 — intervention group
Group type: COMPARATOR
Intervention: High-pressure dilatation (group 2)
Number of subjects: 20
Study 10188788 — intervention group
Group type: EXPERIMENTAL
Intervention: CI‐979/RU35926 (doses of 0.002-1.0 mg, with cholinergic symptoms observed at 2-4 mg)
Number of subjects: 0
Study 10188788 — intervention group
Group type: EXPERIMENTAL
Intervention: CI‐979/RU35926
Number of subjects: 0
Study 2115976 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 404
Study 2115976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 404
Study 893719 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving training
Number of subjects: 25
Study 893719 — intervention group
Group type: COMPARATOR
Intervention: Play-reading groups
Number of subjects: 25
Study 893719 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study 29907079 — intervention group
Group type: EXPERIMENTAL
Intervention: Full navigation intervention
Number of subjects: 1725
Study 29907079 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited contact with navigators
Number of subjects: 1725
Study 29907079 — intervention group
Group type: COMPARATOR
Intervention: No contact with navigators
Number of subjects: 1725
Study 27839238 — intervention group
Group type: EXPERIMENTAL
Intervention: LEAF
Number of subjects: 10
Study 25628469 — intervention group
Group type: EXPERIMENTAL
Intervention: Fit group (score = 0)
Number of subjects: 869
Study 25628469 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate fitness group (score = 1)
Number of subjects: 869
Study 25628469 — intervention group
Group type: EXPERIMENTAL
Intervention: Frail group (score ≥2)
Number of subjects: 869
Study 23649582 — intervention group
Group type: EXPERIMENTAL
Intervention: Visible light-cured (VLC) periodontal surgical dressing (Barricaid)
Number of subjects: 0
Study 23649582 — intervention group
Group type: COMPARATOR
Intervention: Methylmethacrylate acrylic material (DuraLay Inlay Pattern Resin)
Number of subjects: 0
Study 21565137 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiaopi Yishen herbal extract granules (XPYS-HEG)
Number of subjects: 200
Study 21565137 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 19030941 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately cross-linked polyethylene
Number of subjects: 48
Study 19030941 — intervention group
Group type: COMPARATOR
Intervention: Historical polyethylene
Number of subjects: 48
Study 16956475 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of ketorolac administered intravenously 30 minutes before surgery
Number of subjects: 80
Study 16956475 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered intravenously 30 minutes before surgery
Number of subjects: 80
Study 15286547 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ultrasound
Number of subjects: 184
Study 15286547 — intervention group
Group type: COMPARATOR
Intervention: Delayed ultrasound
Number of subjects: 184
Study 10647527 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (five 45-min brisk walking sessions per week at 75.2 +/- 0.5% of maximum heart rate)
Number of subjects: 27
Study 10647527 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 27
Study 10647527 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 27
Study 9028694 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosulpiride (25 mg t.i.d. orally for 6 months)
Number of subjects: 40
Study 9028694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 8122737 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed information group
Number of subjects: 40
Study 8122737 — intervention group
Group type: COMPARATOR
Intervention: Routine information group
Number of subjects: 40
Study 3303693 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaxolon treatment for 20 days
Number of subjects: 34
Study 3303693 — intervention group
Group type: COMPARATOR
Intervention: Control placebo group
Number of subjects: 34
Study 29543566 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib (6 months) followed by trastuzumab (12 months)
Number of subjects: 615
Study 29543566 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab (12 months)
Number of subjects: 615
Study 26952346 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (10 mg/kg)
Number of subjects: 60
Study 26952346 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 60
Study 24961960 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-Q intubating laryngeal airway
Number of subjects: 50
Study 24961960 — intervention group
Group type: COMPARATOR
Intervention: Flexible laryngeal mask airway
Number of subjects: 50
Study 22832395 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative digital dilatation of the internal cervical ostium (group I)
Number of subjects: 94
Study 22832395 — intervention group
Group type: COMPARATOR
Intervention: No dilatation (group II)
Number of subjects: 94
Study 19945340 — intervention group
Group type: EXPERIMENTAL
Intervention: EVT 201 1.5mg
Number of subjects: 149
Study 19945340 — intervention group
Group type: EXPERIMENTAL
Intervention: EVT 201 2.5mg
Number of subjects: 149
Study 19945340 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 18506387 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine (Apo) 7 microg/kg sc, administered in seven injections at 2-hour intervals
Number of subjects: 18
Study 18506387 — intervention group
Group type: COMPARATOR
Intervention: Placebo (physiological saline), administered in seven injections at 2-hour intervals
Number of subjects: 18
Study 15585311 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapamycin-eluting stent
Number of subjects: 32
Study 15585311 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stent
Number of subjects: 32
Study 15585311 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent
Number of subjects: 32
Study 12856872 — intervention group
Group type: EXPERIMENTAL
Intervention: Qi-training
Number of subjects: 0
Study 12856872 — intervention group
Group type: EXPERIMENTAL
Intervention: Qi-therapy
Number of subjects: 0
Study 12856872 — intervention group
Group type: COMPARATOR
Intervention: Sham training
Number of subjects: 0
Study 12856872 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 0
Study 10774682 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg oral artemether
Number of subjects: 8
Study 10774682 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg intramuscular artemether
Number of subjects: 8
Study 10774682 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg suppository artemether
Number of subjects: 8
Study 10774682 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg oral artesunate (Guillin formulation)
Number of subjects: 8
Study 10774682 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg oral artesunate (Arenco formulation)
Number of subjects: 8
Study 10774682 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg oral dihydroartemisinin
Number of subjects: 8
Study 8689881 — intervention group
Group type: EXPERIMENTAL
Intervention: EE-GTD (gestodene 75 micrograms + ethinylestradiol 30 micrograms)
Number of subjects: 19
Study 8689881 — intervention group
Group type: EXPERIMENTAL
Intervention: EE-DSG (desogestrel 150 micrograms + ethinylestradiol 30 micrograms)
Number of subjects: 19
Study 8689881 — intervention group
Group type: COMPARATOR
Intervention: EE-GTD and EE-DSG
Number of subjects: 19
Study 8689881 — intervention group
Group type: EXPERIMENTAL
Intervention: EE-DSG
Number of subjects: 19
Study 1513957 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-mile run/walk test
Number of subjects: 1229
Study 1513957 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/2 mile run/walk test
Number of subjects: 1229
Study 1513957 — intervention group
Group type: EXPERIMENTAL
Intervention: Criterion-referenced reliability (P, percent agreement)
Number of subjects: 1229
Study 6603249 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin stearate 500 mg every six hours for seven days
Number of subjects: 137
Study 6603249 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin or placebo preparation for a further week
Number of subjects: 137
Study 30866943 — intervention group
Group type: COMPARATOR
Intervention: Placebo arm of a double-blind randomized vaccine trial
Number of subjects: 43
Study 29341688 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized benchmarking (RB)
Number of subjects: 0
Study 26912120 — intervention group
Group type: EXPERIMENTAL
Intervention: Board game
Number of subjects: 124
Study 26912120 — intervention group
Group type: COMPARATOR
Intervention: Lecture-based seminar (Control)
Number of subjects: 124
Study 25577869 — intervention group
Group type: EXPERIMENTAL
Intervention: Astaxanthin (25 mg x kg(‐1) x d(‐1) x bw(‐1)) from day 5 to 20 of pregnancy
Number of subjects: 30
Study 25577869 — intervention group
Group type: COMPARATOR
Intervention: L-NAME (125 mg x kg(‐1) x d(‐1) x bw(‐1)) from days 10-20 of pregnancy
Number of subjects: 30
Study 21295843 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg PGF given 48 h prior to embryo collection (Treated cycle)
Number of subjects: 20
Study 21295843 — intervention group
Group type: COMPARATOR
Intervention: 7.5 mg PGF given at embryo collection (Control cycle)
Number of subjects: 20
Study 21295843 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated cycles
Number of subjects: 20
Study 19387413 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (E): selected motion control, stability, or cushioned shoes based on plantar shape (n = 1,079 men and 451 women)
Number of subjects: 2147
Study 19387413 — intervention group
Group type: COMPARATOR
Intervention: Control group (C): received a stability shoe regardless of plantar shape (n = 1,068 men and 464 women)
Number of subjects: 2147
Study 17686164 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant trastuzumab
Number of subjects: 0
Study 17686164 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant trastuzumab
Number of subjects: 0
Study 15535485 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal lavage with normal saline solution (3000 to 6000 ml)
Number of subjects: 21
Study 11499536 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA (oral 8‐MOP plus UVA)
Number of subjects: 24
Study 11499536 — intervention group
Group type: COMPARATOR
Intervention: PUVB (oral 8‐MOP plus UVB)
Number of subjects: 24
Study 9694000 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholics (mean MAO activity 0.34 pmol/hr/10(5) platelets, +/- 0.03)
Number of subjects: 68
Study 9694000 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (mean MAO activity 0.27 pmol/hr/10(5) platelets, +/- 0.03)
Number of subjects: 68
Study 9694000 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 and Type 2 alcoholics
Number of subjects: 68
Study 7946550 — intervention group
Group type: EXPERIMENTAL
Intervention: FM‐85
Number of subjects: 24
Study 7946550 — intervention group
Group type: EXPERIMENTAL
Intervention: EHMF
Number of subjects: 24
Study 7946550 — intervention group
Group type: COMPARATOR
Intervention: Prenan
Number of subjects: 24
Study 3428346 — intervention group
Group type: EXPERIMENTAL
Intervention: muzolimine
Number of subjects: 0
Study 3428346 — intervention group
Group type: COMPARATOR
Intervention: chlorthalidone
Number of subjects: 0
Study 31949093 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide + diet
Number of subjects: 115
Study 31949093 — intervention group
Group type: COMPARATOR
Intervention: Placebo + diet
Number of subjects: 115
Study 30338584 — intervention group
Group type: COMPARATOR
Intervention: Older sexual minority men (OSMM)
Number of subjects: 296
Study 30338584 — intervention group
Group type: EXPERIMENTAL
Intervention: Emerging adult sexual minority men (EA)
Number of subjects: 296
Study 27899101 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory organizational-level intervention (25 months duration, including seminars, workshops, and workplace specific activities)
Number of subjects: 664
Study 27899101 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 664
Study 27899101 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory organizational-level intervention
Number of subjects: 664
Study 27899101 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 664
Study 24816689 — intervention group
Group type: EXPERIMENTAL
Intervention: Staples
Number of subjects: 130
Study 24816689 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular sutures
Number of subjects: 130
Study 22369958 — intervention group
Group type: EXPERIMENTAL
Intervention: Clay modeling (10 min constructing shapes from modeling clay)
Number of subjects: 0
Study 22369958 — intervention group
Group type: EXPERIMENTAL
Intervention: Clay modeling
Number of subjects: 0
Study 22369958 — intervention group
Group type: COMPARATOR
Intervention: Mental arithmetic task (counting backwards by threes)
Number of subjects: 0
Study 22369958 — intervention group
Group type: COMPARATOR
Intervention: Simpler verbal task (counting by ones)
Number of subjects: 0
Study 20536477 — intervention group
Group type: EXPERIMENTAL
Intervention: Strip patch test
Number of subjects: 787
Study 20536477 — intervention group
Group type: COMPARATOR
Intervention: Patch test
Number of subjects: 787
Study 18396028 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) maneuver
Number of subjects: 16
Study 18396028 — intervention group
Group type: EXPERIMENTAL
Intervention: Thixotropy conditioning of inspiratory muscles
Number of subjects: 16
Study 18396028 — intervention group
Group type: COMPARATOR
Intervention: Without intervention (control)
Number of subjects: 16
Study 15691561 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Number of subjects: 42
Study 15691561 — intervention group
Group type: COMPARATOR
Intervention: Bimatoprost 0.03%
Number of subjects: 42
Study 14523186 — intervention group
Group type: EXPERIMENTAL
Intervention: Care Ambassador (CA)
Number of subjects: 299
Study 14523186 — intervention group
Group type: EXPERIMENTAL
Intervention: Care Ambassador plus psychoeducational modules (CA+)
Number of subjects: 299
Study 14523186 — intervention group
Group type: COMPARATOR
Intervention: Standard multidisciplinary diabetes care (SC)
Number of subjects: 299
Study 11764108 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable RBC (AEeliteFlo, Revolution, UltraSeal XT, Flow-It)
Number of subjects: 50
Study 11764108 — intervention group
Group type: COMPARATOR
Intervention: Hybrid RBC (control group)
Number of subjects: 50
Study 8860097 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics (95% thiazides and related agents) with high dietary sugar intake
Number of subjects: 2899
Study 8860097 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics (95% thiazides and related agents) with low dietary sugar intake
Number of subjects: 2899
Study 8860097 — intervention group
Group type: COMPARATOR
Intervention: Other antihypertensive drugs
Number of subjects: 2899
Study 1512524 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen (400 mg/day)
Number of subjects: 27
Study 1512524 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole (225 mg/day) plus Acetylsalicylic Acid (1 g/day)
Number of subjects: 27
Study 1512524 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 27
Study 6721524 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthralin paste covered with semipermeable paper tape
Number of subjects: 12
Study 6721524 — intervention group
Group type: COMPARATOR
Intervention: Control sites (symmetrical)
Number of subjects: 12
Study 30803503 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-dried bilberry (40 g/d) and standard medical therapy
Number of subjects: 50
Study 30803503 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving standard medical therapy alone
Number of subjects: 50
Study 30400984 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Dry Needling plus stretching
Number of subjects: 130
Study 30400984 — intervention group
Group type: COMPARATOR
Intervention: Stretching alone
Number of subjects: 130
Study 25823387 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-grain bread (5 slices, 150g; 48% carbohydrates; 32% fat)
Number of subjects: 40
Study 25823387 — intervention group
Group type: COMPARATOR
Intervention: Walnuts (56g; 8% carbohydrates; 84% fat)
Number of subjects: 40
Study 25823387 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher VAT (299 cm²) and higher BMI (32.4 kg/m²) in individuals with increased e-TEF response to bread compared to lower e-TEF response (VAT 223 cm², BMI 30.0 kg/m²); p = 0.024 and p = 0.013 respectively
Number of subjects: 40
Study 25218720 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating companion wearing overweight prosthesis (fatsuit)
Number of subjects: 0
Study 25218720 — intervention group
Group type: COMPARATOR
Intervention: Eating companion not wearing overweight prosthesis
Number of subjects: 0
Study 25218720 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating companion serving healthily (small amount of pasta, large amount of salad) with prosthesis
Number of subjects: 0
Study 25218720 — intervention group
Group type: COMPARATOR
Intervention: Eating companion serving healthily (small amount of pasta, large amount of salad) without prosthesis
Number of subjects: 0
Study 25218720 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating companion serving unhealthily (large amount of pasta, small amount of salad) with prosthesis
Number of subjects: 0
Study 25218720 — intervention group
Group type: COMPARATOR
Intervention: Eating companion serving unhealthily (large amount of pasta, small amount of salad) without prosthesis
Number of subjects: 0
Study 22338863 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid infusion (AA group, n = 22)
Number of subjects: 40
Study 22338863 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid and glucose infusion (AAGlu group, n = 18)
Number of subjects: 40
Study 22338863 — intervention group
Group type: COMPARATOR
Intervention: Control group (AA group)
Number of subjects: 40
Study 20207123 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula with 130 mg DHA per day
Number of subjects: 0
Study 20207123 — intervention group
Group type: COMPARATOR
Intervention: Formula with 0 mg DHA per day (control)
Number of subjects: 0
Study 17221933 — intervention group
Group type: EXPERIMENTAL
Intervention: Secnidazole 500 mg oral dosage
Number of subjects: 20
Study 17221933 — intervention group
Group type: COMPARATOR
Intervention: Reference secnidazole tablets
Number of subjects: 20
Study 15730173 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.7-mm hysteroscope
Number of subjects: 371
Study 15730173 — intervention group
Group type: COMPARATOR
Intervention: 4-mm hysteroscope
Number of subjects: 371
Study 15730173 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 371
Study 14518728 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided diagnostic system using neural network classifiers for classification of hepatic lesions.
Number of subjects: 0